Reuters logo
BRIEF-Newlink Genetics Q2 loss per share $1.12
July 29, 2016 / 12:26 PM / a year ago

BRIEF-Newlink Genetics Q2 loss per share $1.12

July 29 (Reuters) - Newlink Genetics Corp :

* Q2 loss per share $1.12

* Implemented a significant restructuring program following may results of impress phase 3 study of algenpantucel-l

* Reducing headcount from approximately 230 to approximately 130

* Recorded $12.3 million in restructuring expenses in q2

* Winding down hyperacute cellular immunotherapy clinical trials that do not include a checkpoint inhibitor combination

* In q3, company expects to record small additional charges relating to closing or reduction of leased facilities Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below